n-nitrosoiminodiacetic acid has been researched along with naltrexone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, AJ; Knudsen, HK; Roman, PM; Rothrauff, TC | 1 |
| Costello, E; Novo, P; Nunes, EV; Rotrosen, J; Shulman, M; Weiss, R | 1 |
1 review(s) available for n-nitrosoiminodiacetic acid and naltrexone
| Article | Year |
|---|---|
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Naltrexone; Narcotic Antagonists; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
1 other study(ies) available for n-nitrosoiminodiacetic acid and naltrexone
| Article | Year |
|---|---|
The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Diffusion of Innovation; Follow-Up Studies; Health Services Research; Humans; Naltrexone; Nitrosamines; Organizational Culture; Organizational Innovation; Substance Abuse Treatment Centers; Taurine; United States | 2010 |